[Experiences in administration of antimetabolites in treatment of dermatomyosis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000963:Antimetabolites / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003882:Dermatomyositis / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D012189:Retrospective Studies; D000637:Transaminases / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D000963:Antimetabolites; D015122:Mercaptopurine; D000637:Transaminases; D001379:Azathioprine; D011241:Prednisone
Erfahrungen mit der Anwendung von Antimetaboliten bei der Behandlung der Dermatomyositis.